PARSIPPANY, N.J.--(BUSINESS WIRE)--May 20, 2015--
Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that Dave
Stack, president, chief executive officer and chairman of Pacira
Pharmaceuticals, is scheduled to present an overview of the company at
the following investor conferences in June:
Jefferies 2015 Global Healthcare Conference at 11:30 a.m. ET in New
York on Monday, June 1, 2015.
Goldman Sachs 36th Annual Global Healthcare Conference at
10:40 a.m. PT in Rancho Palos Verdes, California on Tuesday, June 9,
Live audio webcasts of the Pacira presentations can be accessed by
visiting the “Investors & Media” section of the company’s website at
investor.pacira.com. Replays of the webcasts will be archived on the
Pacira website for two weeks following the respective presentation dates.
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s flagship product,
EXPAREL® (bupivacaine liposome injectable suspension), indicated for
single-dose infiltration into the surgical site to produce postsurgical
analgesia, was commercially launched in the United States in April 2012.
EXPAREL and two other products have successfully utilized DepoFoam®, a
unique and proprietary product delivery technology that encapsulates
drugs without altering their molecular structure, and releases them over
a desired period of time. Additional information about Pacira is
available at www.pacira.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150520005815/en/
Source: Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc.
Jessica Cho, 973-254-3574